IndraLab

Statements


KCNH2 activates CRC. 2 / 2
| 2

reach
"Blockade of Either NHE1 or K V 11.1 Inhibits Lateral Motility of CRC Cells."

reach
"Notable are hERG1 upregulation in PC, gastric cancer (GC) and CRC, leading to enhanced cancer angiogenesis and invasion, and KCNQ1 down-regulation in CRC, where KCNQ1 expression is associated with enhanced disease-free survival in stage II, III, and IV disease."